Public Scrutiny Accelerates Durable Healthcare Business Building

Andrew Dudum of Hims & Hers makes a bold case for embracing public markets early, not as an exit, but as a crucible for building durable, consumer-centric healthcare businesses. This conversation reveals the often-unseen advantage of embracing public scrutiny for driving performance and attracting top-tier talent, particularly those with grit forged in crisis. It highlights how a relentless focus on customer outcomes, rather than short-term profits, can reshape entire industries, even when it means challenging entrenched players. Leaders in growth-stage companies, especially those in regulated industries, will find strategic clarity in understanding how to build long-term value by prioritizing mission alignment, operational excellence, and a willingness to disrupt the status quo, even when it generates friction.

The Uncomfortable Advantage of Public Scrutiny

The prevailing narrative often paints public markets as a burdensome constraint, a relentless quarterly grind that stifles innovation. Andrew Dudum, however, reframes this perception, arguing that the public eye, far from being a hindrance, is a potent accelerant for building resilient, high-performance companies. He posits that the daily scrutiny and the need to set and meet aggressive 90-day benchmarks force a level of discipline and focus that can easily elude private entities. This constant pressure cooker environment, he suggests, is not just about survival but about thriving. It’s a "boot camp" that demands consistent delivery, fostering a culture where "you have to deliver."

This public crucible is also a powerful magnet for talent. Dudum emphasizes that the public market forces a company to articulate a compelling, long-term vision, not just for investors, but for potential employees. This clarity attracts individuals who are not only skilled but also deeply aligned with the mission. He champions hiring individuals who have navigated significant challenges, citing examples like his CFO who managed through Uber’s COVID-induced crisis and his Chief Product Officer who experienced Robinhood's GameStop volatility. This isn't about seeking out crisis, but about valuing "grit"--the resilience and composure needed to navigate the inevitable disruptions in a category as dynamic and regulated as healthcare. The contrast with a cozy private environment, where the stakes might feel lower, is stark. The public markets, in Dudum's view, are where true competitive mettle is tested and refined.

"When you're private, it's so easy to get cozy. You know, the worst-case scenario, if you got some VCs that call you and they're stressed out about something, but the public markets, it's like, it's boot camp. You have to deliver."

This perspective challenges the conventional wisdom that companies should remain private for as long as possible to avoid external pressures. Dudum’s experience suggests that embracing public accountability early, as Hims & Hers did, can be a strategic advantage, forcing the organization to mature rapidly and build a foundation of demonstrable performance and robust talent acquisition. The implication is that companies that can withstand and even leverage this intense scrutiny are better positioned for sustained, long-term growth.

The Portfolio Approach to Healthcare Innovation

Hims & Hers operates not as a single-product company, but as a sophisticated portfolio of distinct healthcare businesses, a strategy that shields it from the volatility of any single market trend. Dudum pushes back against the common perception that the company is solely defined by its latest headline-grabbing category, whether it be erectile dysfunction, hair loss, or weight loss. Instead, he describes a decentralized approach, akin to a venture incubator, where multiple clinical categories are explored and scaled independently. This diversification is not merely about risk mitigation; it's about building a durable, adaptable business that can continuously evolve with the rapidly changing landscape of health and wellness.

This "bets" approach allows Hims & Hers to be a "public shell for innovation." Rather than rushing to be first to market, Dudum prioritizes being best in market. This means meticulously vetting clinical protocols, ensuring supply chain integrity, and building unwavering trust with consumers. For instance, in the burgeoning peptide market, Hims & Hers will not be an early entrant but will wait until they can offer a clinically sound, high-quality, and reliably sourced product. This patient, quality-first approach builds brand equity that transcends any single product cycle.

"My net-net takeaway is I don't think we actually need to be first ever in market. I want to be best in market."

The strategy is to curate the most impactful advancements in health and wellness--from new diagnostics and devices to emerging therapies and even lifestyle trends like saunas--and make them accessible at scale. This requires a deep understanding of market dynamics and a willingness to experiment, funding some ventures aggressively while others are strategically starved or ring-fenced for exploration. This portfolio mindset is what allows Hims & Hers to navigate the inherent unpredictability of healthcare innovation, ensuring that the business remains relevant and valuable over the long term by constantly adapting to new scientific discoveries and consumer needs.

The Unseen Power of Brand Marketing: Consistency Over Novelty

In the fast-paced world of direct-to-consumer brands, there's a constant temptation to chase the next novel campaign, the latest trend, or the most exciting experiential marketing stunt. Andrew Dudum, however, argues that for true brand building, especially in a complex category like healthcare, consistency is paramount, even if it feels less exciting. He draws a clear distinction between feeling good about marketing efforts and them actually driving business results. Throwing dollars at an "out-of-home campaign in New York" once, while fun and visible, is a recipe for losing money if it’s not part of a sustained, integrated effort.

The real power of brand marketing, as Dudum sees it, lies in consistent, often "randomized" appearances that create repeated touchpoints over time. It’s not about a single, splashy event, but about the cumulative effect of multiple hits, delivered in diverse ways, that embed the brand into the cultural consciousness. This sustained presence elevates brand trust and cultural relevance, signaling to consumers that the brand is a consistent, reliable force.

"The thing early companies struggle with when it comes to communications and their brand is they get bored of saying the same thing and then they move on to the next thing."

This requires immense discipline, particularly as companies scale. The internal drive to constantly innovate messaging can, paradoxically, undermine brand strength. Great brands, Dudum suggests, are built by repeating the core message--why the company exists, who it serves, and the value it delivers--in myriad ways, week after week, year after year. This consistency, while less glamorous than chasing novelty, is the engine that builds enduring brand loyalty and market leadership, especially in a sector where trust is a critical differentiator.

Key Action Items

• Embrace Public Market Discipline: If your company is at a stage where predictable revenue and long-term orientation are possible, seriously consider the strategic advantages of going public early to drive performance and attract talent. (Immediate to 12 months)
• Prioritize Grit in Hiring: Actively seek out and hire individuals who have demonstrated resilience and the ability to thrive under pressure, especially in roles critical to navigating disruption. (Ongoing)
• Cultivate a Portfolio Mindset: Structure your innovation efforts as a portfolio of bets, focusing on being the best in chosen categories rather than merely first, ensuring quality and trust over speed. (Ongoing)
• Invest in Consistent Brand Messaging: Commit to a disciplined, consistent brand narrative that repeats core messages across various channels, even when it feels repetitive internally. (Ongoing)
• Develop a Verticalized Data Strategy: Invest in owning the infrastructure for data collection and analysis (e.g., at-home diagnostics) to create a powerful, long-term loss leader that drives patient engagement and informs future offerings. (12-24 months for significant investment)
• Focus on Patient Outcomes as the Primary Incentive: Align your business model so that your revenue is directly tied to customer health and happiness, creating a powerful feedback loop for continuous improvement. (Immediate)
• Champion Price Transparency and Consumer Choice: Actively work to dismantle complex distribution models (like PBMs) and advocate for direct-to-consumer access to healthcare services and products at clear, affordable prices. (Ongoing)